| Price | 970.00p on 10-04-2026 at 10:21:35 |
|---|---|
| Change | 14.00p 1.46% |
| Buy | 966.00p |
| Sell | 958.00p |
| Last Trade: | Buy 615.00 at 965.20p |
| Day's Volume: | 16,431 |
| Last Close: | 956.00p |
| Open: | 970.00p |
| ISIN: | GB0004559349 |
| Day's Range | 970.00p - 970.00p |
| 52wk Range: | 532.00p - 1,000.00p |
| Market Capitalisation: | £309.46m |
| VWAP: | 962.80106p |
| Shares in Issue: | 31.90m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 615 | 965.20p | Ordinary |
11:21:33 - 10-Apr-26 |
| Buy* | 103 | 965.20p | Ordinary |
11:09:00 - 10-Apr-26 |
| Buy* | 3 | 966.00p | SI Trade |
11:05:07 - 10-Apr-26 |
| Unknown* | 0 | 966.00p | SI Trade |
11:05:07 - 10-Apr-26 |
| Unknown* | 0 | 958.00p | SI Trade |
11:05:07 - 10-Apr-26 |
| Buy* | 40 | 965.00p | Ordinary |
10:52:48 - 10-Apr-26 |
| Buy* | 45 | 965.00p | Ordinary |
10:52:14 - 10-Apr-26 |
| Buy* | 1,000 | 964.1133p | Ordinary |
10:51:51 - 10-Apr-26 |
| Buy* | 5,190 | 963.30p | Ordinary |
10:45:24 - 10-Apr-26 |
| Buy* | 619 | 963.30p | Ordinary |
10:14:55 - 10-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 11:32 am | RNS | Net Asset Value(s) |
| 8th Apr 2026 11:50 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 5:15 pm | RNS | Transaction in Own Shares |
| 7th Apr 2026 11:56 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 10:25 am | RNS-R | Portfolio company Soleno acquired by Neurocrine |
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Apr 2026 12:02 pm | RNS | Net Asset Value(s) |
| 31st Mar 2026 2:55 pm | RNS-R | IBT portfolio company Apellis acquired by Biogen |
| 31st Mar 2026 12:00 pm | RNS | Net Asset Value(s) |
| 30th Mar 2026 11:46 am | RNS | Net Asset Value(s) |
